Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Medical Genetics

Mapping the Diagnosis: Imaging, Labs, and Genetics

At a Glance

Leigh syndrome is diagnosed using a combination of brain MRIs, blood tests for metabolic markers like lactate, and advanced genetic testing. Identifying the exact genetic mutation through whole exome or genome sequencing is crucial for confirming the diagnosis and finding treatable subtypes.

Diagnosing Leigh syndrome is often described as a “diagnostic odyssey”—a journey through various tests to find a specific answer. Because this syndrome can be caused by mutations in over 100 different genes, doctors use a combination of “footprints” (MRI and blood work) and the “blueprint” (genetic testing) to confirm the diagnosis [1][2].

The MRI “Footprint”

An MRI is often the first tool used when Leigh syndrome is suspected. Doctors look for specific patterns in the brain that suggest energy failure.

  • Bilateral, Symmetrical Lesions: This is the “classic” finding. It refers to areas of cellular stress or damage that appear on both sides of the brain in the exact same spots [3][4].
  • Basal Ganglia and Brainstem: These are the areas most commonly affected because they require the most energy to manage movement and basic life functions like breathing [3][5].
  • Important Note: A “normal” MRI does not completely rule out Leigh syndrome. In some patients, the characteristic lesions may not appear until later in the disease or may be located in other areas like the cerebellum [3][6].

Metabolic Markers: Lactate and Pyruvate

When the “power plants” (mitochondria) in the cells aren’t working properly, they can’t burn fuel (glucose) cleanly. This leads to a buildup of “exhaust” in the body, which doctors measure through blood or cerebrospinal fluid (CSF) tests [7].

  • Lactate: High levels of lactate often indicate that the cells are forced to use an inefficient backup system to create energy because the main system is failing [7][4].
  • Pyruvate: This is a molecule the body uses to make energy. The ratio between lactate and pyruvate can help doctors narrow down which specific part of the energy production line is broken [8].

Genetic Testing: The Definitive Answer

While MRIs and blood tests provide clues, genetic testing is the only way to get a definitive diagnosis [9]. Finding the specific gene involved is vital for several reasons:

  1. Identifying Treatable Subtypes: Some rare forms of Leigh-like syndrome, such as PDHC deficiency or SLC19A3 defects, may respond to high doses of vitamins like thiamine (B1) or biotin [10][8].
  2. Ending the Odyssey: Tests like Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS) look at thousands of genes at once to find the exact “glitch” [11][12]. Practically, these tests usually just require a simple blood draw or a cheek swab from the patient and sometimes their parents.
  3. Future Planning: Knowing the gene (e.g., SURF1, LRPPRC, MT-ATP6, NDUFS4) tells doctors whether the mutation was inherited from both parents or just the mother, which is essential for family planning [13][14].

Understanding Your Diagnostic Report

You may see these terms on your medical reports:

  • Pathogenic Variant: A genetic change that is known to cause disease [13].
  • VUS (Variant of Uncertain Significance): A genetic change has been found, but scientists aren’t sure yet if it causes the disease or is just a normal human variation [11].
  • Leigh-like Syndrome: Used when a patient has many symptoms of Leigh syndrome, but their MRI or genetic tests don’t perfectly match the “classic” definition [15].

Empowerment Checklist

  • [ ] Request a copy of the MRI report. Look for the words “symmetrical,” “basal ganglia,” or “brainstem.”
  • [ ] Ask for the genetic test results. Ensure you know if it was a “Mitochondrial Panel,” “WES,” or “WGS.”
  • [ ] Check for thiamine-responsiveness. Ask your doctor if the specific mutation is one that could benefit from targeted vitamin supplementation [8].
  • [ ] Monitor lactate levels. Keep a log of these levels during routine checkups and when ill.

Common questions in this guide

What does an MRI show if a patient has Leigh syndrome?
An MRI typically reveals bilateral, symmetrical lesions in the basal ganglia and brainstem. However, a normal MRI does not completely rule out the condition, as these characteristic findings can sometimes appear later in the disease process.
Why do doctors test lactate and pyruvate levels for Leigh syndrome?
High levels of lactate and pyruvate in the blood or cerebrospinal fluid indicate that the cells' mitochondria are failing to produce energy correctly. Measuring these metabolic markers helps doctors pinpoint where the energy production system is broken.
Can genetic testing find treatable forms of Leigh syndrome?
Yes, genetic testing can identify rare forms of Leigh-like syndrome, such as PDHC deficiency or SLC19A3 defects. These specific genetic variations may respond to targeted, high-dose vitamin therapies like thiamine or biotin.
What does a Variant of Uncertain Significance (VUS) mean on my child's report?
A VUS on a genetic report means a genetic change was found, but scientists are not yet sure if it is the cause of the disease or simply a normal, harmless human variation. It often requires further monitoring or testing of family members to understand its impact.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do the MRI results show the 'classic' symmetrical lesions in the basal ganglia or brainstem, or are the findings atypical?
  2. 2.If the initial genetic panel or Whole Exome Sequencing is negative, when should we consider Whole Genome Sequencing (WGS)?
  3. 3.Could this case be a treatable subtype, such as thiamine-responsive PDHC deficiency or a biotin-responsive disorder?
  4. 4.How do the lactate and pyruvate levels in the blood and CSF help you understand which part of the energy production is failing?
  5. 5.Are there any specific biochemical markers, like elevated organic acids, that point toward a metabolic defect other than a respiratory chain issue?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Novel intronic variant in NDUFS7 gene results in mitochondrial complex I assembly defect with early basal ganglia and midbrain involvement with progressive neuroimaging findings.

    Oikarainen J, Hinttala R, Nayebzadeh N, et al.

    Mitochondrion 2025; (81()):102007 doi:10.1016/j.mito.2025.102007.

    PMID: 39894241
  2. 2

    Clinical Characteristics of Early-Onset and Late-Onset Leigh Syndrome.

    Hong CM, Na JH, Park S, Lee YM

    Frontiers in neurology 2020; (11()):267 doi:10.3389/fneur.2020.00267.

    PMID: 32351444
  3. 3

    The neuroimaging of Leigh syndrome: case series and review of the literature.

    Bonfante E, Koenig MK, Adejumo RB, et al.

    Pediatric radiology 2016; (46(4)):443-51 doi:10.1007/s00247-015-3523-5.

    PMID: 26739140
  4. 4

    Leigh syndrome in an infant: autopsy and histopathology findings.

    Saini AG, Chatterjee D, Bhagwat C, et al.

    Autopsy & case reports 2021; (11()):e2021334 doi:10.4322/acr.2021.334.

    PMID: 34805005
  5. 5

    Biallelic variants in the NDUFAF6 cause mitochondrial respiratory complex assembly defects associated with Leigh syndrome in probands.

    Zhou Y, Zeng X, Zhang L, et al.

    Molecular genetics and metabolism reports 2024; (41()):101168 doi:10.1016/j.ymgmr.2024.101168.

    PMID: 39720739
  6. 6

    Involvement of Cerebellum in Leigh Syndrome: Case Report and Review of the Literature.

    Chourasia N, Adejumo RB, Patel RP, Koenig MK

    Pediatric neurology 2017; (74()):97-99 doi:10.1016/j.pediatrneurol.2017.05.008.

    PMID: 28739363
  7. 7

    A meta-analysis and systematic review of Leigh syndrome: clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations.

    Chang X, Wu Y, Zhou J, et al.

    Medicine 2020; (99(5)):e18634 doi:10.1097/MD.0000000000018634.

    PMID: 32000367
  8. 8

    Schizophrenia-like symptoms in a patient with Leigh syndrome.

    Satogami K, Takahashi S, Kose A, Shinosaki K

    Asian journal of psychiatry 2017; (25()):249-250 doi:10.1016/j.ajp.2016.12.012.

    PMID: 28262162
  9. 9

    Novel NARS2 variant causing leigh syndrome with normal lactate levels.

    Tanaka R, Takeguchi R, Kuroda M, et al.

    Human genome variation 2022; (9(1)):12 doi:10.1038/s41439-022-00191-z.

    PMID: 35508527
  10. 10

    Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options.

    Gerards M, Sallevelt SC, Smeets HJ

    Molecular genetics and metabolism 2016; (117(3)):300-12.

    PMID: 26725255
  11. 11

    Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study.

    Rosina E, Pezzani L, Apuril E, et al.

    Molecular genetics & genomic medicine 2024; (12(1)):e2316 doi:10.1002/mgg3.2316.

    PMID: 38041506
  12. 12

    Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations.

    Chung CCY, Hue SPY, Ng NYT, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2023; (25(9)):100896 doi:10.1016/j.gim.2023.100896.

    PMID: 37191093
  13. 13

    Genetic analysis of 280 children with unexplained developmental delay or intellectual disability using whole exome sequencing.

    Xu J, Su W, Wang Y, et al.

    BMC pediatrics 2024; (24(1)):766 doi:10.1186/s12887-024-05245-5.

    PMID: 39587513
  14. 14

    Utility of Whole Exome Sequencing for Genetic Diagnosis of Previously Undiagnosed Pediatric Neurology Patients.

    Kuperberg M, Lev D, Blumkin L, et al.

    Journal of child neurology 2016; (31(14)):1534-1539 doi:10.1177/0883073816664836.

    PMID: 27572814
  15. 15

    Deep Brain Stimulation in Leigh-Like Syndrome Due to DNM1 Pathogenic Variant.

    Villa-Villegas L, Lira-Jaime LG, Farías-Moreno KC, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2025; (15()):32 doi:10.5334/tohm.1017.

    PMID: 40717768

This page explains the diagnostic process for Leigh syndrome for educational purposes only. Always consult a geneticist or neurologist to properly interpret your specific MRI, lab, and genetic testing results.

Get notified when new evidence is published on Leigh syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.